Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial. - Goodall RL; Meredith SK; Nunn AJ; Bayissa A; Bhatnagar AK; Bronson G; Chiang CY; Conradie F; Gurumurthy M; Kirenga B; Kiria N; Meressa D; et al. (Lancet (London, England), 2022)